Mildred Lundgren: These 5 Proposals Are A Clear Road Map for The Future And We Support Them Wholeheartedly
Mildred Lundgren, Chairman of the Board at HHT Sweden, shared on LinkedIn:
”We at HHT Sweden applaud this post and stand behind every single point!
For those of us struggling with a rare diagnosis like HHT (Hereditary Hemorrhagic Telangiectasia), faster diagnosis is not just a matter of better quality of life – it’s crucial for preventing life-threatening complications such as stroke and bleeding.
These five proposals are a clear road map for the future and we support them wholeheartedly.
We look forward to the Government now prioritising these measures and securing the funding required for the strategy to become a reality.”
Quoting Rare Diseases Sweden‘s post:
”Time for a focus on rare health conditions!
In Sweden, 500,000 people live with a rare health condition.
Despite this, they often have to wait years for a diagnosis, face regional differences in care and do not have access to treatments in time.
The government has promised a national strategy – but without money, it risks becoming an empty symbolic act.
We know that long-term investments work – cancer care is the proof.
Now the same effort is required for rare diagnoses.
Here are five suggested measures that would make a big difference for patients with rare health conditions:
- SEK 500 million/year for faster diagnosis and care.
- A national coordinator who drives the strategy forward.
- Better support for patient organisations – so every voice is heard.
- Strengthened role for the Centre for Rare Diseases.
- Faster access to new treatments.
It is time to move from words to action.”
Read the full article here.
Article: Time to focus on rare health conditions
Stay updated with Hemostasis Today.
-
Feb 24, 2026, 16:18Salmaan Dalvi: Mapping Rare Diseases Across East and Central Africa
-
Feb 24, 2026, 16:16Wolfgang Miesbach: Game‑Changing Data on Intensive FVIII Replacement in Haemophilia A with Hypertrophic Synovium
-
Feb 24, 2026, 16:01Is It Safe to Briefly Stop Anticoagulation After VTE? – RPTH Journal
-
Feb 24, 2026, 15:58Anastasia Conti: Honored to Receive the Roche Foundation Grant for Independent Research in Onco-Hematology
-
Feb 24, 2026, 15:55Courtney Lawrence: Targeted Donor Screening Reduces Transfusion-Transmitted Babesia Cases
-
Feb 24, 2026, 15:30Aswin K Mohan: Practical Tips for Preparing Before, During, and After Blood Donation
-
Feb 24, 2026, 15:24Stéphanie Forté: The Hidden Burden of Stroke in Adults Living with Sickle Cell Disease
-
Feb 24, 2026, 15:13Tagreed Alkaltham: Equity in Emergency Care Through a Blood Bank Lens
-
Feb 24, 2026, 14:57Joseph Raffaele: Can Improving Mitochondrial Quality in Immune Cells Alter Immune Aging Markers?